Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Work Tenaciously, Pursuit Excellence
Genobio Tries to Be a Brave Pathpaver
On December 5th,2015, the marketing management team of Era Biology held an outdoor training.
Every member of this team nee...
Era Biology will host global live webinar at 8th June 2022 8:30 (GMT +08:00). The webinar will be in Spanish. The webinar will focus on using lateral flow assay method to detect carbapenem-resistan...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will be in Spanish. The webinar will talk about complete solutions for aspergillus galactomannan te...